Noopept (Omberacetam) Powder

Buy Noopept (Omberacetam) Powder Online

Noopept, also known as Omberacetam or GVS-111, is a synthetic proline-containing dipeptide ester developed as a potent nootropic compound. It has been investigated for memory, cognitive impairment, neuroprotection, and adaptation to physical stress.

Product Information

Noopept has been studied in Russian clinical literature as a cognitive and neuroprotective agent. Human studies have used 10-20 mg/day, while preclinical research has explored mechanisms involving neurotrophic signaling, oxidative stress, inflammation, and glutamate-related neurotoxicity.

How It Works

Noopept appears to influence multiple neuronal pathways rather than acting through a single receptor. Research has associated it with neurotrophic signaling, antioxidant activity, modulation of glutamate-related toxicity, and effects on memory consolidation and retrieval.

POTENTIAL BENEFITS

1. Supports Memory Research

Noopept has been investigated for memory acquisition, consolidation, and retrieval. Human clinical research has reported improvements in selected cognitive measures in people with cognitive impairment.

2. Neuroprotective Research

Preclinical research has reported protection against ischemic and excitotoxic neuronal damage. These findings have contributed to Noopept's reputation as a neuroprotective as well as nootropic compound.

3. Cognitive-Function Support

Clinical studies have examined Noopept in patients with cognitive impairment associated with stroke, vascular disease, and trauma. A published study used 20 mg/day for two months and reported improved cognitive measures.

4. Anxiolytic and Adaptogenic Research

Noopept has also been investigated for anxiety-related effects and adaptation to environmental stress. Human volunteer research reported effects on psychological and physical performance under challenging environmental conditions.

Dosage

Published human studies have used 10 mg twice daily (20 mg/day), including a clinical study involving patients with stroke-related cognitive impairment. Earlier clinical-development literature also describes 5 mg and 10 mg tablet strengths. These doses reflect historical clinical research rather than a recommendation for unsupervised use.

Side Effects

Reported clinical studies suggest relatively good short-term tolerability, but possible headache, irritability, sleep changes, gastrointestinal effects, or other CNS symptoms may occur. Long-term safety data remain limited, especially outside the populations studied clinically.

References

1. Gudasheva TA, et al. The original novel nootropic and neuroprotective agent noopept. Eksperimental'naia i klinicheskaia farmakologiia. 2002. PMID: 12596521. PubMed
2. Amelin AV, Iliukhina AIu, Shmonin AA. Noopept in the treatment of mild cognitive impairment in patients with stroke. Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(10 Pt 1):44-46. PMID: 22500312. PubMed
3. Shabanov PD, Ganapol'skii VP, Aleksandrov PV. Meteoadaptogenic properties of peptide drugs in healthy volunteers. Eksperimental'naia i klinicheskaia farmakologiia. 2007;70(6):41-47. PMID: 18318195. PubMed
4. Szeleszczuk L, et al. Physicochemical and structural analysis of N-phenylacetyl-L-prolylglycine ethyl ester (Noopept). 2024. PMID: 39298839. PubMed

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to see how purchases actually work on this site.